Dr. Žarko Vrbica
Claim this profileFudan University Shanghai Cancer Center
Studies Non-Small Cell Lung Cancer
1 reported clinical trial
2 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage III
Stage IV
More about Žarko Vrbica
Clinical Trial Related5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Žarko Vrbica has experience with
- Alectinib
- Brigatinib
Breakdown of trials Žarko Vrbica has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Žarko Vrbica specialize in?
Žarko Vrbica focuses on Non-Small Cell Lung Cancer and other conditions. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Žarko Vrbica currently recruiting for clinical trials?
No, Žarko Vrbica is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Žarko Vrbica has studied deeply?
Yes, Žarko Vrbica has studied treatments such as Alectinib, Brigatinib.
What is the best way to schedule an appointment with Žarko Vrbica?
Apply for one of the trials that Žarko Vrbica is conducting.
What is the office address of Žarko Vrbica?
The office of Žarko Vrbica is located at: Fudan University Shanghai Cancer Center, Dubrovnik, Dubrovnik-Neretva 20 000 Croatia. This is the address for their practice at the Fudan University Shanghai Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.